SCHEMBL24422984

SCHEMBL24422984

COC(=O)c1ccc(OC)c(/N=N\c2cc(C(=O)OC)ccc2OC)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.60
▸ KMT2A Q03164 5/20 0.54
▸ CA1 P00915 4/20 0.50
▸ CA2 P00918 4/20 0.50
▸ MEN1 O00255 4/20 0.50
▸ CA12 O43570 3/20 0.50
▸ CA7 P43166 3/20 0.50
▸ CA9 Q16790 3/20 0.50
▸ CA14 Q9ULX7 3/20 0.50
▸ XDH P47989 1/20 0.50
▸ CYP2C9 P11712 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ LMNA P02545 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ ATM Q13315 2/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ USP2 O75604 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422981 0.88 MAPT (0.58) MAPTKMT2ACA1CA2MEN1
SCHEMBL6118516 0.82 MAPT (0.53) MAPTKMT2ACA1CA2MEN1
SCHEMBL10478021 0.82 TSHR (0.47) MAPTKMT2ACA1CA2MEN1
Veratric Acid Methyl Ester SCHEMBL29573244 0.81 MAPT (0.86) MAPTKMT2ACA1CA2MEN1
Veratric Acid Methyl Ester SCHEMBL2050732 0.81 MAPT (0.86) MAPTKMT2ACA1CA2MEN1
SCHEMBL24423486 0.80 TDP1 (0.52) MAPTKMT2ACA1CA2MEN1
SCHEMBL5169870 0.78 MAPT (0.64) MAPTKMT2ACA1CA2MEN1
SCHEMBL35861 0.78 MAPT (0.64) MAPTKMT2ACA1CA2MEN1
Isovanillic Acid Methyl Ester SCHEMBL29497236 0.78 CA1 (0.69) MAPTKMT2ACA1CA2MEN1
SCHEMBL29678875 0.78 MAPT (0.64) MAPTKMT2ACA1CA2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144757-A1 Compound, Carbon Dioxide Absorption/Release Agent, Carbon Dioxide Collection Method, and Carbon Dioxide Collection Apparatus TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144757-A1 Compound, Carbon Dioxide Absorption/Release Agent, Carbon Dioxide Collection Method, and Carbon Dioxide Collection Apparatus CBR3, CNR1, CBR1 MAPT 4836/4885KMT2A 2192/4885CA1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback